摘要
目的:探讨恩替卡韦(ETV)治疗慢性乙型病毒性肝炎患者的疗效。方法:收治慢性乙型病毒性肝炎患者90例,随机分为治疗组和对照组。对照组采用常规护肝基础治疗,治疗组在对照组基础上加用恩替卡韦,比较两组治疗效果。结果:治疗后,治疗组的肝功能恢复情况、HBeAg阴转率及HBV-DNA阴转率均优于对照组(P<0.05)。结论:恩替卡韦治疗慢性乙型病毒性肝炎患者的疗效显著。
Objective：To explore the efficacy of entecavir in the treatment of patients with chronic viral hepatitis B.Methods：90 patients with chronic viral hepatitis B were selected.They were randomly divided into the treatment group and the control group.The control group was treated with conventional liver protection therapy,and the treatment group added entecavir on the basis of the control group.We compared the therapeutic effect of two groups.Results：After treatment,in the treatment group,the recovery of liver function,the rate of HBe Ag negative conversion and the rate of HBV-DNA negative conversion were better than those in the control group（P〈0.05）.Conclusion：The efficacy of entecavir in the treatment of patients with chronic viral hepatitis B was significant.
出处
《中国社区医师》
2017年第32期67-67,69,共2页
Chinese Community Doctors
